Treatment of Obesity in Patients With Diabetes

IN BRIEF More than 90% of patients with diabetes have overweight or obesity. Whereas weight gain and obesity worsen insulin resistance, weight loss slows the progression of diabetes complications. Given the elevated risk for diabetes complications in patients with obesity, clinicians must understand how to treat obesity in their patients with diabetes, including providing counseling and behavioral management, referral to weight loss programs, and medication management. This article summarizes guidelines for diagnosing and managing obesity in people with diabetes.

• Publication year

  2017

• Venue

  Diabetes Spectrum

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/ds17-0030PMID 29151713PMCID 5687113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms, Pathophysiology, and Management of Obesity

  2017cited by this paper
• Effect of a Long‐Term Intensive Lifestyle Intervention on Cognitive Function: Action for Health in Diabetes Study

  2017cited by this paper
• Standards of Medical Care in Diabetes—2017 Abridged for Primary Care Providers

  2017cited by this paper
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

  2017cited by this paper
• Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects

  2017cited by this paper
• Maintenance of Weight Loss After Initiation of Nutrition Training

  2017cited by this paper
• Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study

  2017cited by this paper
• Maternal obesity is associated with congenital anomalies of the kidney and urinary tract in offspring

  2017cited by this paper
• Guideline‐concordant weight‐loss programs in an urban area are uncommon and difficult to identify through the internet

  2016cited by this paper
• Association of the Magnitude of Weight Loss and Physical Fitness Change on Long-term CVD outcomes: The Look AHEAD Study

  2016cited by this paper
• A systematic review of commercial weight loss programmes’ effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus

  2016cited by this paper
• Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers

  2016cited by this paper
• Proportion of selected congenital heart defects attributable to recognized risk factors.

  2016cited by this paper
• Dietary and Behavioral Approaches in the Management of Obesity.

  2016influential reference
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.

  2016cited by this paper
• Understanding the Effect of Obesity on Fertility Among Reproductive-Age Women.

  2016cited by this paper
• Efficacy of commercial weight-loss programs: an updated systematic review.

  2015cited by this paper
• Satisfaction with primary care provider involvement is associated with greater weight loss: Results from the practice-based POWER trial.

  2015cited by this paper
• Pharmacological management of obesity: an endocrine Society clinical practice guideline.

  2015cited by this paper
• Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis.

  2014cited by this paper
• Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes

  2014cited by this paper
• Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes

  2014cited by this paper
• Are Breaks in Daily Self-Weighing Associated with Weight Gain?

  2014cited by this paper
• Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes

  2014cited by this paper
• Insights from the POWER Practice-Based Weight Loss Trial: A Focus Group Study on the PCP’s Role in Weight Management

  2014cited by this paper
• 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

  2014cited by this paper
• Perceived judgment about weight can negatively influence weight loss: a cross-sectional study of overweight and obese patients.

  2014cited by this paper
• The Look AHEAD Trial: A Review and Discussion of Its Outcomes

  2014cited by this paper
• Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study

  2014cited by this paper
• Weight Loss, Glycemic Control, and Cardiovascular Disease Risk Factors in Response to Differential Diet Composition in a Weight Loss Program in Type 2 Diabetes: A Randomized Controlled Trial

  2014cited by this paper
• AHA / ACC / TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines and The Obesity Society Endorsed

  2014influential reference
• A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program

  2013cited by this paper
• Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

  2013cited by this paper
• New drug therapies for the treatment of overweight and obese patients.

  2013cited by this paper
• Insights from the POWER Practice-Based Weight Loss Trial: A Focus Group Study on the PCP’s Role in Weight Management

  2013cited by this paper
• 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

  2013cited by this paper
• Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes

  2013cited by this paper
• Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study

  2012cited by this paper
• Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial

  2012cited by this paper
• Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity

  2012cited by this paper
• Screening for and Management of Obesity in Adults: U.S. Preventive Services Task Force Recommendation Statement

  2012cited by this paper
• Two-year sustained weight loss and metabolic benefits with controlled-release Phentermine/Topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

  2012cited by this paper
• National survey of US primary care physicians’ perspectives about causes of obesity and solutions to improve care

  2012cited by this paper
• Do the five A's work when physicians counsel about weight loss?

  2011cited by this paper
• Contents of Forthcoming Issues

  2011cited by this paper
• Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial

  2011cited by this paper
• Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force

  2011cited by this paper
• Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

  2011cited by this paper
• A randomised controlled trial to compare a range of commercial or primary care led weight reduction programmes with a minimal intervention control for weight loss in obesity: the Lighten Up trial

  2010cited by this paper
• articlePhysicians ' use of the 5 As in counseling obese patients : is the quality of counseling associated with patients ' motivation and intention to lose weight ?

  2010cited by this paper
• Temporal patterns in overweight and obesity in Type 1 diabetes

  2009cited by this paper
• Physician Respect for Patients with Obesity

  2009cited by this paper
• Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss

  2009cited by this paper
• Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy

  2009cited by this paper
• Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.

  2009cited by this paper
• 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

  2009cited by this paper
• The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study

  2009cited by this paper
• Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

  2008cited by this paper
• Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes *

  2008cited by this paper
• Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

  2008cited by this paper
• Randomized Trial of a Multifaceted Commercial Weight Loss Program

  2007cited by this paper
• Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.

  2007cited by this paper
• Consistent Self‐monitoring of Weight: A Key Component of Successful Weight Loss Maintenance

  2007cited by this paper
• Internalization of Weight Bias: Implications for Binge Eating and Emotional Well‐being

  2007cited by this paper
• Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial.

  2005cited by this paper
• Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

  2003cited by this paper
• Weight loss counseling revisited.

  2003cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Evaluating primary care behavioral counseling interventions: an evidence-based approach.

  2002cited by this paper
• Lifestyle Intervention in Overweight Individuals With a Family History of Diabetes

  1998cited by this paper
• Barriers to providing nutrition counseling by physicians: a survey of primary care practitioners.

  1995cited by this paper
• Beneficial health effects of modest weight loss

  1992cited by this paper
• Beneficial health effects of modest weight loss.

  1992cited by this paper
• UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group.

  1990cited by this paper

• Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial.

  2025cites this paper
• Novel Model Predicts Type 2 Diabetes Mellitus Patients Complicated With Metabolic Syndrome Using Retrospective Dataset From First Affiliated Hospital of Shenzhen University, China

  2025cites this paper
• Oral versus subcutaneous semaglutide weight loss outcomes after two years among patients with type 2 diabetes in a real-world database

  2025cites this paper
• Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison

  2025cites this paper
• Association between changes in body composition and physical function after intensive behavioral weight-loss intervention: a Look AHEAD trial subgroup analysis.

  2025cites this paper
• The potential effect of polyphenols in emerging pharmacological liver targets for glucose regulation and insulin resistance: a review.

  2025cites this paper
• Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.

  2025cites this paper
• Association between glucagon-like peptidase 1 receptor agonist and obesity-related cancer in overweight or obese patients with type 2 diabetes: a nationwide cohort study.

  2025cites this paper
• Effect of Tirzepatide on the Risk of Developing Type 2 Diabetes Mellitus Among the People Living With Obesity or Overweight: A Systematic Review

  2025cites this paper
• Health-related quality of life in racial and ethnic minority adults with type 2 diabetes: validity and responsiveness of the EQ-5D-3L

  2025cites this paper
• Exploring the therapeutic potential of extract in targeting localized adiposity.

  2025cites this paper
• Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse models

  2025influential citation
• Readiness to Change for Weight Loss in Adults with Type 2 Diabetes with Obesity: Determinants in a Cross-sectional Study

  2025cites this paper
• Practical Applications of Russian DPP4 Inhibitor Gosogliptin in “Palitra” Large-Scale Observational Study

  2024cites this paper
• Adolescents’ Diabetes Self-Management Regimens and Outcomes During the COVID-19 Pandemic: A Scoping Review

  2024cites this paper
• Long‐term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial

  2024cites this paper
• Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.

  2024cites this paper
• Overview Of Patient Treatment Compliance Type 2 Diabetes Mellitus At Seyegan Health Center Sleman District In 2023

  2024cites this paper
• Real-World Effectiveness of Oral Semaglutide in Indian Adult Diabetic Patients: Evaluation of EMR-based Data

  2024cites this paper
• Web-Based Intervention to Act for Weight Loss in Adults With Type 2 Diabetes With Obesity (Chance2Act): Protocol for a Nonrandomized Controlled Trial

  2024cites this paper
• Retatrutide.

  2024cites this paper
• Impacts of dietary animal and plant protein on weight and glycemic control in health, obesity and type 2 diabetes: friend or foe?

  2024cites this paper
• Role of pharmacists in the management of patients with obesity

  2024cites this paper
• The Role of Screening, Risk Factors, and Early Intervention in Preventing Diabetes in the Obese Population: A Systematic Review

  2024cites this paper
• A Comparative Study of Metformin and/or Glimepiride on Non-Migrant South Indian Middle-Aged Type 2 Diabetes Mellitus Patients

  2024cites this paper
• Low-carbohydrate diet for people with type 2 diabetes mellitus.

  2024cites this paper
• Experiences of living with overweight/obesity and early type 2 diabetes in Singapore—a qualitative interview study

  2024cites this paper
• Probiotic induced synthesis of microbiota polyamine as a nutraceutical for metabolic syndrome and obesity-related type 2 diabetes

  2023cites this paper
• Patient perspectives about treatment preferences for obesity with complications

  2023cites this paper
• Excessive generalized and visceral adiposity is associated with a higher prevalence of diabetic retinopathy in Caucasian patients with type 2 diabetes.

  2023cites this paper
• The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives

  2023cites this paper
• Role of the tripartite motif‐containing (TRIM) family of proteins in insulin resistance and related disorders

  2023cites this paper
• Indeks Massa Tubuh dan Kadar Gula Darah pada Pasien Diabetes Mellitus Tipe 2

  2023cites this paper
• Perspectives in weight control in diabetes - BI 456906.

  2023cites this paper
• Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis

  2023cites this paper
• Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups.

  2023cites this paper
• Obesity Duration and Cardiometabolic Disease

  2023cites this paper
• Trajectory of glycated haemoglobin over time, using real‐world data, in type 2 diabetes patients with obesity on a U‐100 basal‐bolus insulin regimen

  2023cites this paper
• Integrated network pharmacology and molecular modeling approach for the discovery of novel potential MAPK3 inhibitors from whole green jackfruit flour targeting obesity-linked diabetes mellitus

  2023cites this paper
• Stevioside ameliorates hyperglycemia and glucose intolerance, in a diet-induced obese zebrafish model, through epigenetic, oxidative stress and inflammatory regulation.

  2022cites this paper
• Measurement of Revascularization in the Hind Limb After Experimental Ischemia in Mice.

  2022cites this paper
• APPLICATION OF DIABETES SELF-MANAGEMENT EDUCATION AND SUPPORT TO NUTRITIONAL STATUS, EATING HABITS AND GLYCEMIC CONTROL IN OUTPATIENTS WITH TYPE II DIABETES MELLITUS

  2022cites this paper
• Toward Development of a Diabetic Synovium Culture Model

  2022cites this paper
• Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial

  2022cites this paper
• The Effects of Yoga on Cardiovascular Risk Factors among Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis

  2022cites this paper
• Racial and ethnic disparities in cardiometabolic disease and COVID-19 outcomes in White, Black/African American, and Latinx populations: Physiological underpinnings

  2022cites this paper
• Insulin Resistance and Biological Aging: The Role of Body Mass, Waist Circumference, and Inflammation

  2022cites this paper
• Bacteroides ovatus-mediated CD27− MAIT cell activation is associated with obesity-related T2D progression

  2022cites this paper
• A Comparison Study on the Therapeutic Effect of High Protein Diets Based on Pork Protein versus Soybean Protein on Obese Mice

  2022cites this paper
• Effect of Near-Infrared Vein Finder Technology on Success Rate of Cannulation in Obese Diabetic Patients

  2022cites this paper
• Prioritizing the glucose-lowering medicines for type 2 diabetes by an extended fuzzy decision-making approach with target-based attributes

  2022cites this paper
• Impact of talk test based aerobic exercise on glycaemic control and anthropometric measures among patients with type 2 diabetes mellitus

  2022cites this paper
• The role of short-chain fatty acids on insulin sensitivity: a systematic review and meta-analysis

  2022cites this paper
• Effect of apple peel extract on diabetes-induced peripheral neuropathy and wound injury

  2021cites this paper
• Type 2 Diabetes Modifies Skeletal Muscle Gene Expression Response to Gastric Bypass Surgery

  2021cites this paper
• Clinical outcomes in 'diabese' burn patients: A systematic review and meta-analysis.

  2021cites this paper
• Chains of evidence from correlations to causal molecules in microbiome-linked diseases

  2021cites this paper
• The Most Undertreated Chronic Disease: Addressing Obesity in Primary Care Settings

  2021cites this paper
• How exposure to chronic stress contributes to the development of type 2 diabetes: a complexity science approach.

  2021cites this paper
• Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?

  2021cites this paper
• Diabetes Mellitus and Its Implications in Aortic Stenosis Patients

  2021cites this paper
• Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients

  2021cites this paper
• Obesitas, Pola Diet, dan Aktifitas Fisik dalam Penanganan Diabetes Melitus pada Masa Pandemi Covid-19

  2021cites this paper
• Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.

  2021cites this paper
• Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus

  2020cites this paper
• Atherosclerosis in patients with type 1 diabetes.

  2020cites this paper
• A framework to decipher the genetic architecture of combinations of complex diseases: applications in cardiovascular medicine

  2020cites this paper
• Novel Clusters of Adult-Onset Diabetes in a Portuguese Population

  2020cites this paper
• Hemoglobina glicosilada y su asociación con sobrepeso u obesidad en niños y adolescentes del Instituto Ecuatoriano de Seguridad Social La Libertad

  2020cites this paper
• Severe obesity in a specialist type 2 diabetes outpatient clinic: an Australian retrospective cohort study

  2020cites this paper
• Dietary management of cardiovascular risk including type 2 diabetes.

  2020cites this paper
• The Potential of Black Cumin (Nigella sativa, L.) Seeds Extract to Prevent Polyphagia and Weight Loss in Rattus Norvegicus of Diabetes Mellitus-Type 2

  2020cites this paper
• Behavior and Practices of Type 2 Diabetic Patients Regarding Obesity: A Cross-Sectional Study

  2020cites this paper
• The effects of high‐fat diet and metformin on urinary metabolites in diabetes and prediabetes rat models

  2020cites this paper
• Class 3 Obesity in a Multidisciplinary Metabolic Weight Management Program: The Effect of Preexisting Type 2 Diabetes on 6-Month Weight Loss

  2020cites this paper
• Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer

  2020cites this paper
• Impact of Diabetes on Life and Healthy Life Expectancy among Older Women.

  2020cites this paper
• Dietary Fructose Consumption and Triple-Negative Breast Cancer Incidence

  2019cites this paper
• Gastric Bypass Surgery Improves the Skeletal Muscle Ceramide/S1P Ratio and Upregulates the AMPK/ SIRT1/ PGC-1α Pathway in Zucker Diabetic Fatty Rats

  2019cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology.

  2017cites this paper
• Pharmacokinetic drug evaluation of extended release lorcaserin for the treatment of obesity

  2017cites this paper
• Proportion of selected congenital heart defects attributable to recognized risk factors.

  2016cites this paper